This specific laboratory metric quantifies the fraction of total testosterone that is unbound by sex hormone-binding globulin (SHBG) or albumin, making it physiologically active at the cellular level. It represents the true hormonal status available for receptor binding and downstream effect, unlike total testosterone alone which can be misleading. Accurate measurement is paramount for diagnosing symptomatic hypogonadism, as binding proteins heavily influence clinical presentation.
Origin
The need for this measurement arose from clinical observations where men with normal total testosterone levels exhibited classic symptoms of androgen deficiency. “Bioavailable” directly relates to the biological availability for receptor interaction, a core concept in endocrinology. The measurement technique itself has evolved from older calculation methods to direct, highly accurate mass spectrometry techniques.
Mechanism
Testosterone circulates in three states: bound to SHBG, bound weakly to albumin, or free. Only the free fraction, and a small portion weakly bound to albumin, can enter target cells to exert genomic or non-genomic effects. Specialized assays directly measure this unbound fraction, or calculate it using measured SHBG and total testosterone values. This measurement provides a clearer picture of the actual hormonal signal strength acting upon androgen receptors in tissues like muscle, bone, and brain.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.